NK:IO LTD

EC2N 1HQ (London)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£300,000

Mar 21 - Jul 22

Novel small molecule enhanced NK cell immunotherapy

Innovate UK award to NK.IO LIMITED and Andrew Baxendale

£1,585,624

Apr 23 - Mar 25

Enhanced NK cell function and expansion for immunotherapy

Innovate UK award to NK:IO LTD and Andrew Baxendale

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}